Loading clinical trials...
Loading clinical trials...
Cryolipolisis for Subcutaneous Abodomen and Flank Fat Reduction
Sixty healthy subjects aged between 18 and 50 will be randomly allocated into three treatment groups: Conventional Cryolipolysis, Contrast Cryolipolysis or Recovery Reperfusion Cryolipolysis. The region will be treated according to the individual need, in the region of abdomen and flanks. Assessments of body composition will be performed at baseline and 30, 60 and 90 days after randomization. Blood collections will also be performed at baseline and between 14 and 21 days after randomization for evaluation of lipid profile and liver function.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
Yes
Centro de Estudos e Formação Avançada Ibramed.
Amparo, São Paulo, Brazil
Start Date
January 1, 2017
Primary Completion Date
August 1, 2017
Completion Date
October 1, 2017
Last Updated
April 20, 2018
60
ACTUAL participants
Conventional Cryolipolysis
DEVICE
Contrast Cryolipolysis
DEVICE
Reperfusion Cryolipolysis
DEVICE
Lead Sponsor
Universidade Cidade de Sao Paulo
Collaborators
NCT05760248
NCT05155683
NCT04090853
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions